Accordingly, inhibition of GPR68 attenuates inflammation and improves the outcomes in murine disease models of colitis and chronic kidney failure-induced cardiac inflammation and fibrosis [16,33]. This evidence concerns the gene GPR68 and chronic renal failure syndrome.